International external quality assurance of JAK2 V617F quantification
-
Published:2018-12-08
Issue:5
Volume:98
Page:1111-1118
-
ISSN:0939-5555
-
Container-title:Annals of Hematology
-
language:en
-
Short-container-title:Ann Hematol
Author:
Asp JuliaORCID, Skov Vibe, Bellosillo Beatriz, Kristensen Thomas, Lippert Eric, Dicker Frank, Schwarz Jiri, Wojtaszewska Marzena, Palmqvist Lars, Akiki Susanna, Aggerholm Anni, Tolstrup Andersen Morten, Girodon François, Kjær Lasse, Oppliger Leibundgut Elisabeth, Pancrazzi Alessandro, Vorland Marta, Andrikovics Hajnalka, Kralovics Robert, Cassinat Bruno, Coucelo Margarida, Eftimov Aleksandar, Haslam Karl, Kusec Rajko, Link-Lenczowska Dorota, Lodé Laurence, Matiakowska Karolina, Naguib Dina, Navaglia Filippo, Novotny Guy Wayne, Percy Melanie J, Sudarikov Andrey, Hermouet Sylvie, Pallisgaard Niels
Funder
Austrian Science Fund
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference20 articles.
1. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, Garcon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434(7037):1144–1148.
https://doi.org/10.1038/nature03546 2. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR, Cancer Genome P (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365(9464):1054–1061.
https://doi.org/10.1016/S0140-6736(05)71142-9 3. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352(17):1779–1790.
https://doi.org/10.1056/NEJMoa051113 4. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D'Andrea A, Frohling S, Dohner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7(4):387–397.
https://doi.org/10.1016/j.ccr.2005.03.023 5. Lippert E, Boissinot M, Kralovics R, Girodon F, Dobo I, Praloran V, Boiret-Dupre N, Skoda RC, Hermouet S (2006) The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera. Blood 108(6):1865–1867.
https://doi.org/10.1182/blood-2006-01-013540
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|